ROC performance in life sciences and health care worldwide in 2011 and 2017
Between 2011 and 2017, the return on capital (ROC) for life sciences manufacturers decreased from 16.6 percent to 11.9 for pharmaceutical companies and from 13.8 percent to 9.9 percent for medtech companies. This statistic shows the return on capital performance in life sciences and health care worldwide in 2011 and 2017.